Actively Recruiting
A Stakeholder-enhanced Intervention to Improve the Decisional Partnership of Chronic Kidney Disease Dyads (IMPART)
Led by University of Alabama at Birmingham · Updated on 2026-01-26
128
Participants Needed
1
Research Sites
184 weeks
Total Duration
On this page
Sponsors
U
University of Alabama at Birmingham
Lead Sponsor
N
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Using a highly innovative methodology, the Multiphase Optimization Strategy (MOST), the purpose of this study is to pilot test, an optimization trial approach to develop and refine the decision partnering skills of persons with stage 4 chronic kidney disease and their caregivers. Using a 2x2x2 full factorial design, 64 dyads (patients and one identified caregiver) will be randomized to receive one or more lay coach-delivered decision partnering training components, based on Pearlin's Stress-Health Model of Family Caregiving and Rini's Social Support Effectiveness theory. The components include: 1) caregiver coaching on effective decision support (1 vs. 3 sessions); 2) caregiver decision support communication training (1 session vs. none); and 3) patient social support effectiveness psychoeducation (yes vs. no).
CONDITIONS
Official Title
A Stakeholder-enhanced Intervention to Improve the Decisional Partnership of Chronic Kidney Disease Dyads (IMPART)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 years or older
- Documented diagnosis of stage 4 CKD with 2 eGFR values between 15 and 29 within 90 days
- Ability to speak and read English and complete baseline questionnaires
- Patients must have an enrolled caregiver
- Caregivers aged 18 years or older
- Caregivers identified by the patient as a relative, friend, or partner who assists with medical decisions and is unpaid
- Caregivers caring for a patient with CKD
- Ability of caregivers to speak and read English and complete baseline questionnaires
- Caregivers must have an enrolled patient
You will not qualify if you...
- Patients receiving hospice care
- Patients receiving dialysis treatment
- Patients with active unmedicated severe mental illness, moderate to severe dementia, suicidal ideation, uncorrected hearing loss, or active substance abuse
- Caregivers with self-reported unmedicated mental illness, moderate to severe dementia, active suicidal ideation, uncorrected hearing loss, or active substance abuse as determined by study questioning
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shena Gazaway
Birmingham, Alabama, United States, 35294-1150
Actively Recruiting
Research Team
S
Shena Gazaway, Phd, RN
CONTACT
A
Alicia Cole, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
FACTORIAL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
8
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here